Scientists make surprising discovery after attempting to remove dangerous fish from lake: 'It took us 25 years to prove why'
According to the Cornell Chronicle, years of efforts to remove an invasive species of smallmouth bass from an Adirondack lake have led scientists to a surprising discovery about why these efforts have not been successful.
What's happening?
Smallmouth bass may be a native North American species, but the species was only introduced to the Adirondacks in the 1900s. After their introduction, the smallmouth bass did what invasive species do and quickly took over many of the region's lakes, which resulted in significant declines in native fish populations.
However, despite 25 years of efforts to eradicate the smallmouth bass from these lakes, the populations continued to thrive. Now, researchers have published a study with the surprising reason why eradication efforts have failed.
According to the study, which was published in the Proceedings of the National Academy of Sciences journal, efforts to physically remove this species from these lakes to decrease the population size were unsuccessful because, over time, the smallmouth bass evolved to mature earlier and grow more quickly, resulting in smaller fish but a larger overall population.
One of the senior researchers on the study, Peter McIntyre, explained: "Twenty-five years ago, Cornell's Adirondack Fishery Research Program set out to test whether we could functionally eradicate smallmouth bass from a lake. It took us 25 years to prove why the answer is no: the fish evolved to outmaneuver us."
Why are evolving invasive species concerning?
Invasive species, like smallmouth bass, already cause a plethora of problems when introduced to new ecosystems, so if they can evolve to avoid eradication, these issues worsen.
Because invasive species spread so rapidly, they can destroy native species and ecosystems by outcompeting them for food and other vital resources. Invasive species can also introduce new diseases into ecosystems, which can decimate native species populations.
Depending on the type of invasive species, other problems caused by their introduction could include impacted human food supplies, more extreme weather patterns, and altered soil chemistry.
However, by prioritizing and protecting native species, as researchers tried to do in the Adirondacks by removing smallmouth bass, food supplies are protected, the spread of disease is limited, and natural resources are better conserved.
What's being done about the smallmouth bass?
The discovery of the smallmouth bass's evolution to outwit eradication highlights the need to prevent invasive species from entering ecosystems in the first place.
Do you think America does a good job of protecting its natural beauty?
Definitely
Only in some areas
No way
I'm not sure
Click your choice to see results and speak your mind.
However, for the smallmouth bass already in these Adirondack lakes, removing them less often or only removing a particular subset may be the solution. Doing this might reduce the bass's evolutionary need to adapt, but more research will be needed to determine this.
As one researcher said, according to the Cornell Chronicle: "Long-term studies of management efforts are critical, not only for deepening our understanding of natural ecosystems, but also for evaluating the effectiveness of specific management tools."
Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
an hour ago
- Medscape
Ovarian Cancer Risk Rises Soon After IBS Diagnosis
TOPLINE: Women with a new diagnosis of irritable bowel syndrome (IBS) have a significantly higher risk for ovarian cancer at 3 months and 6 months post-diagnosis, but this risk is no longer elevated beyond 8 months. METHODOLOGY: Ovarian cancer often presents with nonspecific symptoms overlapping those of IBS. The frequency of misdiagnosis remains unknown, and not all IBS guidelines recommend screening for ovarian cancer. Researchers conducted a retrospective cohort study using US administrative claims data to compare ovarian cancer incidence in adult women with and without a new IBS diagnosis. Diagnostic codes were used to identify cases of IBS and ovarian cancer. TAKEAWAY: The cohort comprised 9804 women with IBS and 79,804 women without IBS, identified between January 2017 and December 2020. Women with IBS had a significantly higher risk for ovarian cancer at 3 months (hazard ratio [HR], 1.71; P = .02) and 6 months (HR, 1.43; P = .02), but not beyond 8 months post-diagnosis. Women with both IBS and endometriosis had an even greater risk for ovarian cancer at 3 months (HR, 4.20; P = .01), 6 months (HR, 3.52; P = .01), and after 1 year (HR, 2.67; P = .04). Increasing age was significantly associated with higher ovarian cancer incidence only in women younger than 50 years (HR, 1.07; P < .01), regardless of IBS status. IN PRACTICE: 'Identifying patient-specific risk factors, such as chronic pelvic pain or endometriosis, could help develop tailored risk profiles and improve the approach to personalized care in women with IBS-type symptoms,' the authors wrote. SOURCE: This study was led by Andrea Shin, Vatche and Tamar Manoukian Division of Digestive Diseases, University of California, Los Angeles. It was published online in Alimentary Pharmacology & Therapeutics. LIMITATIONS: The use of diagnostic codes for identifying IBS may have led to misclassification or reflected symptoms rather than confirmed and validated diagnosis. DISCLOSURES: This study received support from the National Institutes of Health. Some authors reported serving as consultants, advisors, and/or receiving research support from pharmaceutical and healthcare companies; one author reported having stock options. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Medscape
an hour ago
- Medscape
Benzene in Acne Products: What to Know Now
When an independent laboratory filed a citizen's petition in March 2024, urging the FDA to recall and suspend the sale of acne products containing benzoyl peroxide after finding what it termed unacceptably high levels of benzene in acne products it tested, it ignited a range of reactions in the medical community and consumers. Responses ranged from fear to indifference, with even some dermatologists passing off the request as nonsense. However, concerns about the potential for benzoyl peroxide-containing acne products to break down into benzene, a known human carcinogen, have been ongoing. In recent months, as research has accumulated, so has a clearer picture of the risk. The FDA has taken action, although some contend the agency has not done enough, and experts involved are better focused — and sometimes in closer agreement — on how to move forward to increase safety for the products, considered one of the most effective topical acne treatments and the only effective remedy for many patients. Medscape Medical News reached out to John S. Barbieri, MD, MBA, assistant professor of dermatology at Harvard Medical School and director of the Advanced Acne Therapeutics Clinic at Brigham and Women's Hospital, both in Boston, and David Light, president and co-founder of Valisure, the independent laboratory in New Haven, Connecticut, that filed the petition, asking for an update of what they've found out in recent months (they both have published research recently), what they believe needs to be done moving forward, and their advice on how clinicians should be talking to their patients about the products. 'Right now, to me, it's a nonissue clinically,' said Barbieri, who has researched and written about the issue extensively. 'I don't worry about this in my day-to-day practice.' However, he's adamant that more needs to be done to maximize the safety of the products, that patients need to be educated about precautions they can take, and that manufacturers need to focus on getting the benzene levels in their products to what he and others say is achievable — zero. Product Heterogeneity Researchers have found a wide range of levels of benzene in products. That's good news, so to speak, in regard to fixing the problem. As Barbieri and Christopher Bunick, MD, PhD, associate professor of dermatology at Yale University School of Medicine, New Haven, Connecticut, wrote in a recent Viewpoint in JAMA Dermatology, 'there has been considerable heterogeneity observed between brands and product lines, suggesting opportunities to improve formulation, production, and distribution practices to maximize the safety of benzoyl peroxide-containing products.' The range of benzene found, for instance, in the Valisure analysis leading to the citizen's petition was sometimes over 800 times the FDA's conditional limit of 2 parts per million. The JAMA paper also cites a study, published in May 2025, by Bunick, Light, and others, finding that cold storage may reduce benzene formation, and a study co-authored by Barbieri, which found that leave-on benzoyl peroxide products contained lower concentrations of benzene, possibly because they are often manufactured in smaller batches than washes 'and thus may cool more quickly,' they wrote. Recent Recalls In March 2025, the FDA alerted the public and industry to the results of its testing of 95 acne products with benzoyl peroxide for possible benzene contamination, following the receipt of the Valisure test results. As a result of the FDA alert, six companies voluntarily recalled some of their products, and another company voluntarily recalled its product after its own testing. FDA Input? Under nonbinding FDA guidance issued in December 2023, benzene levels in products using carbomers (thickeners) should not exceed 2 parts per million. Medscape Medical News reached out to the FDA, asking if the agency had any other information pertaining to developments in the manufacturing of benzoyl peroxide acne products. A spokesperson referred only to the March 2025 information about recalls and its finding that more than 90% of the benzoyl peroxide acne products it tested had undetectable or very low levels of benzene. Manufacturers' Mission Manufacturers need to do more, Light and Barbieri agreed, to monitor benzene levels and reduce them. 'I'm quite supportive of the paper they wrote,' Light told Medscape Medical News , referring to the JAMA update co-authored by Barbieri and Bunick. 'I appreciate their push on the manufacturers' side,' a stance Light has taken from the start. Information on exactly what the product manufacturers are doing, even after the March recalls and the FDA testing, is scarce, Light and Barbieri agreed. (Light's analyses have previously been the target of some criticism, contending he is mostly interested in winning lawsuits against companies and boosting profits. He has filed patents related to, among other areas, the prevention of the formation of impurities, including benzene, in drug products such as benzoyl peroxide-containing products. In response, Light said his goals have always been focused on public health and consumer protection. 'Our analyses have not only been rigorously reviewed through the peer-review process in multiple journals,' he said, 'but each of our five FDA Citizen Petitions on benzene contamination in major consumer product categories has been followed by testing and validation by regulators and companies that confirmed unacceptably high levels of benzene and initiated recalls.') The Consumer Health Products Association, a trade group that many of the benzoyl peroxide product manufacturers belong to, posted the following statement on its site after the citizen's petition was filed last year: 'Benzene is not intentionally added to any consumer product, and it is important that proper quality control measures are in place to both detect impurities and reduce potential contamination during the manufacturing process.' But it offered no more specific information about individual manufacturers' procedures or attempts at improvements. Beyond quality control measures, manufacturers must pay attention to shipping and distribution, which can affect benzene levels as temperatures rise, Barbieri said. 'Consumer confidence is really important here,' he added. Manufacturers should also transparently share their benzene data, Barbieri and Light agreed. Besides acne products, according to the FDA, hand sanitizers, aerosol antiperspirants, and sunscreen sprays have been recalled because of benzene concerns. Empowering Patients Meanwhile, clinicians can advise patients to take a number of steps to minimize the risk for benzene exposure, according to Barbieri and Light. Discarding expired products or those that have been exposed to high temperatures — such as being left in a hot car — is one recommendation. Replacing products every 10-12 weeks is also probably wise, Barbieri said, but he concedes that more data is needed about the stability of the products at room temperature. Whether refrigerating the products is better than keeping them at room temperature hasn't been fully researched, he noted. Lowering the temperature does help with benzene formation, Light said. In his studies, he found that a single acne product incubated at 158 °C, similar to a hot car, released benzene at concentrations about 1270 times higher than the US Environmental Protection Agency threshold for cancer risk via long-term inhalation. He also cautions against storing the products in the bathroom medicine cabinet because of the higher temperatures. In addition, consumers shouldn't rely on 'best products' lists based on analyses of benzene levels, Barbieri told Medscape Medical News , because the same product could have been purchased in different ways — such as picking it up from the store directly or ordering it online and then having it sit on a hot doorstep for hours. Be cautious using online retailers and pharmacies, he said, for those reasons — the products could have had potentially higher temperature exposure during shipping. Ultraviolet exposure is similar to heat in its effects, Light pointed out. Barbieri said those who use leave-on products should consider sun protection, which, he added, is a useful general recommendation for acne management in general. Looking Forward: Getting to Zero While progress has been made, and awareness of the risks has increased, there's work to be done, experts agreed. 'It's still an important and relevant issue,' Barbieri said. 'We want to be doing as much as we can to mitigate the risk as much as possible. Even if the risk is 0.00001, if we can make it zero, we should make it zero.' Barbieri and Bunick have reported no relevant disclosures. Light has filed patents related to the prevention of the formation of impurities, including benzene, in drug products, such as benzoyl peroxide products. The Journal of Investigative Dermatology study published in May 2025 was funded by Valisure.
Yahoo
2 hours ago
- Yahoo
Astronauts for Crew-11 fly into KSC ahead of upcoming launch
KENNEDY SPACE CENTER — The business of hurtling humans into space is getting routine on the Space Coast with the fourth flight of a SpaceX Crew Dragon queued up for this week. The crew going for that ride arrived in Florida on Saturday. NASA astronauts Zena Cardman and Mike Fincke, JAXA (Japan Aerospace Exploration Agency) astronaut Kimiya Yui and Roscosmos cosmonaut Oleg Platonov, the quartet for SpaceX's Crew-11 mission to the International Space Station, flew into the former space shuttle landing site at KSC after noon under the searing sun as temperatures on the tarmac climbed into the 90s. 'Sorry for the heat, but it's Florida in the summertime,' said veteran Fincke, who kept cracking jokes and even made bunny ears behind Platonov's head during a photo as the crewmates talked to media. They're slated to lift off as early as 12:09 p.m. Thursday from KSC's Launch Pad 39-A atop a Falcon 9 rocket riding in the Crew Dragon Endeavour. 'We've been training together for over a year now and we are ready to fly,' said Cardman, who is making her first spaceflight. 'As a first-time flyer, this is the first moment when it's really starting to feel real.' They expect at least a six-month stay on board the space station where they will relieve the four members of Crew-10 on board since March. In addition to the two NASA flights this year, SpaceX has flown a private polar orbital mission Fram2 in March and the private Axiom Space Ax-4 mission to the space station last month. The launch is one shy of the five human spaceflight missions from Florida seen in 2024, although it would equal the number of people launching with 16 in space. Both last year's Boeing Starliner CFT mission and the Crew-9 mission only flew up with two crew each instead of four. That was because Crew-9 became the ride home for Starliner astronauts after NASA opted to send Boeing's beleaguered spacecraft home minus crew over safety concerns — and they ultimately had to be ferried home by SpaceX. NASA astronaut Michael Fincke talks about how he started to bald after going to space causing laughter from Crew-11 crewmate and JAXA astronaut Kimiya Yui after they arrived to Kennedy Space Center on Saturday, July 26, 2025 ahead of their planned launch this week to the International Space Station. (Richard Tribou/Orlando Sentinel) NASA astronaut and pilot Michael Fincke gives a handoff wave to Crew-11 crewmate JAXA astronaut Kimiya Yu as NASA astronaut and commander Zena Cardman, left, and Roscosmos cosmonaut Oleg Platonov, right, look on after they arrived to Kennedy Space Center on Saturday, July 26, 2025 ahead of their planned launch this week to the International Space Station. (Richard Tribou/Orlando Sentinel) NASA astronaut and pilot Michael Fincke cracks a joke causing JAXA astronaut Kimiya Yui to break into laughter after they and their fellow Crew-11 crewmates, NASA astronaut and commander Zena Cardman and Roscosmos cosmonaut Oleg Platonov, arrived to Kennedy Space Center on Saturday, July 26, 2025 ahead of their planned launch this week to the International Space Station. (Richard Tribou/Orlando Sentinel) The four members of Crew-11 arrive to Kennedy Space Center on Saturday, July 26, 2025 ahead of their planned launch this week to the International Space Station. From left to right are NASA astronaut and commander Zena Cardman, NASA astronaut and pilot Michael Fincke, JAXA astronaut Kimiya Yui and Roscosmos cosmonaut Oleg Platonov along with his translator. (Richard Tribou/Orlando Sentinel) The four members of Crew-11 arrive to Kennedy Space Center on Saturday, July 26, 2025 ahead of their planned launch this week to the International Space Station. From left to right are NASA astronaut and commander Zena Cardman, NASA astronaut and pilot Michael Fincke, JAXA astronaut Kimiya Yui and Roscosmos cosmonaut Oleg Platonov along with his translator. (Richard Tribou/Orlando Sentinel) Show Caption1 of 6NASA astronaut Michael Fincke, right, raises some bunny ears behind the head Roscosmos cosmonaut Oleg Platonov while posing for photos with their Crew-11 crewmates, NASA astronaut Zena Cardman and JAXA astronaut Kimiya Yui, after arriving at Kennedy Space Center on Saturday, July 26, 2025 ahead of their planned launch this week to the International Space Station. (Richard Tribou/Orlando Sentinel)Expand Endeavour is making a record sixth trip to space, the first of SpaceX's fleet of five Crew Dragons to hit that mark as NASA looks to stretch their utility beyond the original five flights for which they have been certified. Cardman was originally tapped as commander for the Crew-9 mission, but as a rookie, she was bumped in favor of another member of that crew with flight experience. She is now back for Crew-11 as its commander. She becomes the last of 12 NASA astronauts from the 2017 class known as The Turtles to make it space. 'In spaceflight, the journey is often nonlinear. It's just a privilege to be here with this crew, especially. I have the privilege of overlapping with one of my classmates, Jonny Kim, who's currently on board as a member of Expedition 73. I also have the privilege of flying with Kimiya Yui, whose patch has a turtle on it. And so that makes him an honorary turtle in my heart.' Fincke was also reassigned from what was supposed to be Starliner's first operational crew mission, Starliner-1, but shifted to this SpaceX mission as Boeing and NASA continue to work on Starliner's issues. He is making his fourth trip to space having made trips on Soyuz in 2004 and 2008 as well as the penultimate flight of the Space Shuttle Program, STS-134, on Space Shuttle Endeavour in 2011. 'It's been a really interesting journey watching brand new spaceships be built,' Fincke said. 'I'm very proud of our teams, both SpaceX and Boeing, to what they built together and really proud to actually finally fly on a commercial crew spacecraft.' Japan's Yui also was training for a Starliner flight, but is now headed for his second trip to space — having been on a Soyuz mission in 2015. 'My last mission was 10 years ago, so I'm very much looking forward to going back to my home,' he said. Platonov joins Cardman as the second rookie on this mission. The four will be on board when the station reaches a milestone on Nov. 2, which will signify 25 years of continuous occupation. They will be part of Expeditions 73 and 74 along with the three members on board that flew up on a Soyuz. 'I'm personally looking forward to going back up to the space station. I helped build it, and now I get to see it in its full maturity with six other crewmates,' Fincke said. NASA looks to decommission the station after 2030. 'I know it's coming near its time, but this is something that I think that humans should just really remember of all the cool things we can do when we work together constructively,' Fincke said. Solve the daily Crossword
